Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

38.27
+4.0611.87%
Post-market: 38.300.0300+0.08%19:59 EDT
Volume:368.31K
Turnover:13.85M
Market Cap:83.80M
PE:- -
High:39.75
Open:33.90
Low:33.88
Close:34.21
52wk High:391.58
52wk Low:12.38
Shares:2.19M
Float Shares:2.19M
Volume Ratio:1.03
T/O Rate:16.82%
Dividend:1.98
Dividend Rate:5.17%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AST SpaceMobile, Intel, On, Hims, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 11

Hims & Hers Health, Inc. : Citigroup Cuts Target Price to $33 from $35

THOMSON REUTERS
·
Aug 11

Morgan Stanley Adjusts PT on Hims & Hers Health to $28 From $21, Maintains Equalweight Rating

MT Newswires Live
·
Aug 11

Dow Jones Top Company Headlines at 5 am ET: Intel Increases Size of Stock Offering to Raise $20 Billion | Samsung ...

Dow Jones
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)

TIPRANKS
·
Aug 11

Hims & Hers Health Falls After Bigger-than-Expected Q2 Loss

Reuters
·
Aug 11

Hims & Hers Health Shares Down 7.3% Premarket After Co Posts Wider-than-Expected Q2 Loss

THOMSON REUTERS
·
Aug 11

Premarket Movers | Riot Platforms Surges 23%; Plug Power Gains 9%; HIMS Falls 7%; USA Rare Earth, Rocket Lab Drop 8% Each

Tiger Newspress
·
Aug 11

Dow Jones Top Company Headlines at 9 PM ET: South Korea's Hanwha Makes $1 Billion Push into U.S. Naval Shipbuilding | Nvidia, ...

Dow Jones
·
Aug 11

24H | Riot Platforms Jumps 25%; SMCI Climbs 1%; USA Rare Earth Tumbles 8%; Rocket Lab USA Drops 7%

US Overnight
·
Aug 11

Stocks to Watch: Hims & Hers, Rocket Lab, Plug Power, Babcock & Wilcox

Dow Jones
·
Aug 11

Hims & Hers Says Testosterone Outpacing All Drugs Other than Weight-Loss

Dow Jones
·
Aug 11

Hims & Hers Gets 17-Fold Explosion in Overseas Business

Dow Jones
·
Aug 11

Hims & Hers Health Testing Peptide Ingredients Ahead of Expected FDA Decision on Allowing Compounding for the Drugs - Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Expects Gross Margins to Remain Below Historical Levels, Due to International, Weight-Loss Business Expansion - Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Exec Says AI Technology to Lower Prices for Weight-Loss Subscribers in 2026- Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Says Co in Process of Testing Bpc-157 Peptide- Conf Call

THOMSON REUTERS
·
Aug 11

Hims Stock Falls on Earnings. Why a Guidance Hike Isn't Enough.

Dow Jones
·
Aug 11

Hims & Hers Able to Scale Peptide Offering if US Law Allows, CFO Says

Reuters
·
Aug 11

Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11